[Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide]. 2003

Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D008297 Male Males
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
August 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
September 2006, Reumatologia clinica,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
November 2005, The New England journal of medicine,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
July 2001, Internal medicine journal,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
February 2006, The New England journal of medicine,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
February 2006, The New England journal of medicine,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
June 2006, Nature clinical practice. Nephrology,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
May 2009, Journal of the American Society of Nephrology : JASN,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
May 2013, Kidney international,
Isolina Baños, and Miguel Yebra, and José Fernández, and Santiago Ramón y Cajal
November 2005, The New England journal of medicine,
Copied contents to your clipboard!